Options Trading News

October 23, 2012  Tue 1:16 AM CT

Shares of Oncothyreon have been range-bound for the last few weeks, and one trader is looking for that trend to continue for the clinical biopharmaceutical company.

ONTY slipped 0.58 percent to end the session at $5.13, trapped between about $5 and $5.50 since Sept. 27. Shares were above $6.20 before falling into that range, their highest level since gapping down from above $8 in early March.

Total option volume in the name was 11,147, compared to a daily average of just 477, and only 719 were calls. Dominating the volume was a put calendar spread.

A trader bought 5,000 May 5 puts for the ask price of $2.15 and sold the same number of the December 5 puts for the bid price of $0.65, according to optionMONSTER's Depth Charge system.

The trade profits if ONTY remains around $5, with losses possible if shares move too far in either direction. Traders often use calendar spreads if they believe that implied volatility is too high, with greater time decay in nearer-term options.
Share this article with your friends

Related Stories


Oncothyreon attracts bullish trade

September 30, 2015

A call buyer is betting that the cancer-drug developer will weather the current biotechnology selloff and rally next year.


Premium Services

Archived Webinar

Education & Strategy

The covered call and unhedged risk

I have written a few things on the Covered Call Strategy over the last two weeks. Please understand that those two previous articles plus this one do not constitute a proper, fully in-depth lesson on the Covered Call Strategy like we have in our classes at Option Monster Education. I have picked out a few topics that I believe were worth noting and today I am going to add the final one.

View more education articles »